Summary
Altered levels of high density lipoprotein (HDL), low density lipoprotein (LDL), and very-low density lipoprotein (VLDL), as well as apolipoproteins have been previously described in rheumatoid arthritis patients. We have attempted to evaluate the serum triglyceride, total cholesterol, cholesterol in DHL, LDL, apolipoprotein A1 (apo-A1) and apolipoprotein B (apo-B) levels in juvenile chronic arthritis (JCA) and to correlate them with CRP and ESR in the active and non-active stages of JCA. A total of 37 children who fulfilled ARA criteria for the diagnosis of JCA were studied. There were 18 girls and 19 boys. Age range was 2.5–16 years with a mean of 9.5. The mean duration of disease was 1.8 years. Nineteen patients were accepted to have active disease. Eighteen age and sex matched healty children served as controls. Apo-A1 was significantly lower in the active JCA group when compared to inactive patients and healthy controls (both p<0.05). There were significant inverse correlations between apo-A1 and both ESR and CRP levels in these patients (r=0.67, p<0.05 and r=−0.61, p<0.–05, respectively). Although mean LDL levels were numerically lower in the JCA patients (67.2 mg/dl in the active and 68.6 mg/dl in the inactive patients) the difference with healthy controls (91.7 mg/dl) was not statistically significant. There was no significant differences in regard to triglyceride, total cholesterol, cholesterol in HDL, and apo-B levels between neither of the groups. We conclude that JCA patients have a dyslipoproteinaemic state with already altered metabolism of lipids at different stages of the chronic inflammation from active to inactive disease.
Similar content being viewed by others
References
Ilowite, NT., Samuel, P., Ginzler, E., et al. Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum. 1988; 31 (7): 859–863.
Svenson, KLG., Lithel, H., Hällgren, R. et al. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Inter Med 1987; 147: 1912–1916.
Svenson, KLG., Lithell, H., Hällgren, R. et al. Serum lipoprotein inactive rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Arch Inter Med 1987; 147: 1917–20.
Lorber, M., Aviram, M., Linn, S. et al. Hypocholesterolemia and abnormal high-density lipoprotein in rheumatoid arthritis. Br J Rheumatol 1985; 24: 250–255.
Lazarevic MB, Vitic J, Mladenovra V, et al. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum 1992; 22: 172–180.
Ilowite, NT., Samuel, P., Beseler, L. et al. Dyslipoproteinemia in juvenile rheumatoid arthritis. J Pediatr 1989; 114: 823–826.
Cassidy, JT., Petty, RE. Juvenile rheumatoid arthritis. In: Textbook of Pediatric Rheumatology, New York (2nd ed.): Churchill Livingstone, 1990: 113–220.
Dahlquist, SR., Jonsson, SW., Dahlen, G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis. 1991; 50: 366–368.
Rowe, IF., Souter, N., Troyner, TM. et al. Circulating human C-reactive protein binds very low density lipoproteins. Clin Exp Immunol 1984; 58: 237–244.
Cabana, VB., Gewurz, H., Siegel, JN. Inflammation-induced changes in rabbit CRP and plasma lipoproteins. J Immunol 1983: 130: 1736–42.
Cabana, VG., Siegel, JN., Sobesin, SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apalipoproteins. J Lipid Res 1989; 30: 39.
Beutler, BA., Cerami, A. Recombinant IL1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 1985: 135(6) 3969–3971.
Strandberg, O. Anaemia in rheumatoid arthritis Acta Med Scand 1966; 179 (suppl): 53–60.
Lazarevic, MB, Vitic, J., Miladenovic, MV. et al. Antilipoprotein antibodies in rheumatoid arthritis. Sem Arth Rheum 1993; 22: 385–97.
Miller, GJ., Miller, NE. Plasma high density lipoprotein concentration and the development of ischaemic heart disease. Lancet 1975; i: 16–18.
Dahlen, GH. Lp(a) Lipoprotein in cardiovascular disease. Atherosclerosis. 1994; 108: 111–126.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bakkaloglu, A., Kirel, B., Ozen, S. et al. Plasma lipids and lipoproteins in juvenile chronic arthritis. Clin Rheumatol 15, 341–345 (1996). https://doi.org/10.1007/BF02230355
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02230355